Clinical Trials Directory

Trials / Unknown

UnknownNCT03813498

Hepatitis C Patient Management and Family Health Education

Health Education Based on We Media to Promote Patient Adherence to HCV Treatment: A Nationwide Online Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
China Liver Health · Academic / Other
Sex
All
Age
18 Years – 69 Years
Healthy volunteers
Not accepted

Summary

INTRODUCTION: Hepatitis C virus (HCV) is recognized as the leading cause of chronic liver disease worldwide. However, the screening rate and treatment rate of HCV-infected patients in China is low, which increases the burden of patients and the infection risk of their family members. WeChat, an instant messaging software, is used in a very high proportion in China. Health promotion based on WeChat public platform is a very convenient and effective way of health education. Therefore, this study plans to apply WeChat to conduct health intervention for HCV-infected patients. The objective is to explore the effect of We-media-based health promotion method on the detection rate and treatment rate of HCV-infected and their family members. METHOD: Recruitment will be conduct in 10 hospitals in Jilin, Beijing, Henan and Anhui provinces. The subjects should be patients new diagnosed with hepatitis C at the hospital and aged 18 to 69. After signing the consent form, eligible participants were selected through the inclusion and exclusion criteria. 1000 participants will be recruited for the trial. After completing an baseline reseach by a online questionnaire, patients will be randomly assigned to receive a targeted short article on HCV weekly or a general health article with no mention of HCV. The intervention will last three months and a follow-up will be conduct at three month after the last intervention. OUTCOMES: The primary outcome is antiviral therapy. The secondary outcomes are cognition and attitude towards hepatitis C, factors influencing antiviral therapy, time to first treatment and the compliance of treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHCV articlesThe intervention group receive a targeted short article on HCV from WeChat weekly.
BEHAVIORALgeneral health articlesThe control group receive a general health article with no mention of HCV from WeChat weekly.

Timeline

Start date
2019-01-01
Primary completion
2019-11-01
Completion
2019-11-01
First posted
2019-01-23
Last updated
2019-01-23

Source: ClinicalTrials.gov record NCT03813498. Inclusion in this directory is not an endorsement.